JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8604 GNF 5

Target: Bcr-Abl

Summary: Bcr-Abl inhibitor
A8652 JK 184

Summary: Hh signaling inhibitor

Soluble in DMSO
A8672 RLLFT-NH2

Summary: Protease-activated receptor agonist

Soluble to 2 mg/mL
A8681 Ro3280

Target: PLK

Summary: PLK1 inhibitor,potent and highly selective

≥27.2 mg/mL
A8688 TAK-715
2 Citation

Summary: p38 MAPK inhibitor

≥40 mg/mL
B1050 Delavirdine mesylate

Summary: Non-nucleoside reverse transcriptase inhibitor

insoluble in H2O; insoluble in EtOH; ≥58.3 mg/mL
B1260 CC-401

Summary: JNK inhibitor,ATP-competitive

≥19.4 mg/mL
B5389 Mirin

Summary: A potent inhibitor of the Mre11-Rad50-Nbs1 (MRN)-ATM pathway

insoluble in EtOH; insoluble in H2O; ≥9.3 mg/mL
B5521 LY 78335

Summary: phenylethanolamine-N-methyltransferase (PNMT) inhibitor

<22.65 mg/mL
B5572 Ro 51

Summary: dual P2X3 and P2X2/3 antagonist

<47.43 mg/mL